• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/43

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

43 Cards in this Set

  • Front
  • Back

Fibrosis

The healing process that results after persistent tissue damage.

Labile cells

Renewing cells, that can proliferate rapidly.


Ex. epithelium of skin/gut, and bone marrow

Stable cells

Cells that are capable of regeneration, but only do so when necessary


Ex. Fibroblasts, endothelial cells, bone, cartilage, liver, kidney, exocrine pancreatic acini

Permanent cells

Cells that cannot proliferate/regenerate after a certain stage in development


Ex. Myocardiocytes & neurons

Granulation Tissue

Healing process that includes fibroblasts and connective tissue bridging the gap created by the wound. Also includes angiogenesis, where the blood vessels run perpendicular (toward the surface) to the connective tissue.

First Intention Healing

When the damage is clean cut, with minimal infection and foreign bodies, the healing process is by primary union.


1. Scab formation & neutrophil infiltration


2. Basal layer proliferation & granulation tissue


3. Fibrous union between sides and remodeling

Secondary Intention Healing

Result of a less-than-perfect wound healing. Usually due to delayed healing, due to necrotic debris, foreign material, infection, or excessive granulation tissue.


1. Blood clot & acute inflammation


2. Granulation tissue, scab, and basal layer proliferation


3. Scab is shed & granulation tissue brings sides together.


4. Puckering of healed wound and/or depressed scar.

Anisocytosis

Varying cell size

Anisokaryosis

Varying nuclear size

Pleomorphism

Abnormal cell shape

Hamartoma

Disorganized mature tissue in a normal anatomic location. They are enlargements but typically not malignant.

Choristoma

Normal mature tissue at an abnormal site


Ex. Dermoid

Benign

Unlikely to cause harm. Often slow growing and can compress (but not invade) surrounding tissue.


Well demarcated with recognizable cell types.

Malignant

Likely to cause harm. Often rapid growth and invasive qualities. Acquire their own blood supply.


Poorly demarcated and can contain hemorrhage and necrosis.

Carcinoma

Malignant neoplasm of epithelial origin

Sarcoma

Malignant neoplasm of mesenchymal origin

Metastasis

Spread of neoplasm to secondary sites

Round Cell Neoplasm

Distinct circular cells histologically.


Ex. lymphoma, mast cell tumor, plasma cell tumor

Epithelial Neoplasm

Neoplasm arising from organ cells


Ex. liver, kidney, pancreas, skin

Papilloma

Exophitic growth from cutaneous or mucocutaneous surface

Polyp

Growth projecting into a lumen.

Mesenchymal Neoplasm

Arises from embryonic mesodermal origin, and consisting of cells that make up supportive tissue.


Ex. Bone, muscle, tendon, nerve, fascia, vessels, cartilage

Fibroma

Benign fibrocyte tumor

Lipoma

Benign adipocyte tumor

Osteoma

Benign bone tumor

Adenoma

Benign gland tumor

Angioma or Hemangioma

Benign endothelial tumor

Chondroma

Benign cartilage tumor

Melanocytoma or melanoma

Benign melanocyte tumor

Pheochromocytoma

Benign adrenal medulla tumor

Fibrosarcoma

Malignant fibrocyte tumor

Osteosarcoma

Malignant bone tumor

Adenocarcinoma

Malignant gland tumor

Transitional cell carcinoma

Malignant bladder epithelial tumor

Leiomyosarcoma

Malignant smooth muscle tumor

Rhabdomyosarcoma

Malignant skeletal muscle tumor

Liposarcoma

Malignant adipose tumor

Lymphosarcoma

Malignant lymphocyte tumor

Malignant melanoma

Malignant melanocyte tumor

Chondrosarcoma

Malignant cartilage tumor

Hemangiosarcoma

Malignant endothelial tumor

Carcinogenesis

Initiation - irreversible alteration


Promotion - selective outgrowth of initiated cells


Progression - development of features of malignancy due to genetic changes

Latency

Time before a tumor is clinically detectable


Smallest detectable mass is 1 cm in diameter (10^9 cells)